By Carlo Martuscelli

 

Fresenius SE & Co. KGaA (FRE.XE) said Tuesday that net profit and sales both rose in the third quarter, and backed its full-year outlook.

Net income was 444 million euros ($492.4 million), up from EUR419 million in the previous-year period, while sales grew 7.9% to EUR8.42 billion.

The German provider of health products and services backed its earnings guidance for 2019. The company sees sales growth at constant currency rates of between 4% to 7%, while net income on a comparable basis is expected to be flat.

At Fresenius Medical Care (FME.XE), the company's dialysis division, net profit rose 17% to EUR333 million, while sales increased by 8.9% to EUR4.42 billion.

 

Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com; @carlomartu

 

(END) Dow Jones Newswires

October 29, 2019 02:44 ET (06:44 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
Von Feb 2024 bis Mär 2024 Click Here for more Fresenius SE & Co KGaA Charts.
Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
Von Mär 2023 bis Mär 2024 Click Here for more Fresenius SE & Co KGaA Charts.